Unknown

Dataset Information

0

Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia.


ABSTRACT:

Background

Little is known about the comparative effects of different glucocorticoids on the adrenal and growth hormone (GH) axes in children with congenital adrenal hyperplasia (CAH). We sought to compare the effects of hydrocortisone (HC), prednisone (PDN), and dexamethasone (DEX) in children with classic CAH and to investigate a potential role of pharmacogenetics.

Methods

Subjects were randomly assigned to three sequential 6-week courses of HC, PDN, and DEX, each followed by evaluation of adrenal hormones, IGF-1, GH, and body mass index (BMI). Single nucleotide polymorphism (SNP) analysis of genes in the glucocorticoid pathway was also performed.

Results

Nine prepubertal subjects aged 8.1 ± 2.3 years completed the study. Mean ACTH, androstenedione, and 17-hydroxyprogesterone (17-OHP) values were lower following the DEX arm of the study than after subjects received HC (p ≤ 0.016) or PDN (p ≤ 0.002). 17-OHP was also lower after HC than PDN (p < 0.001). There was no difference in IGF-1, GH, or change in BMI. SNP analysis revealed significant associations between hormone concentrations, pharmacokinetic parameters, and variants in several glucocorticoid pathway genes (ABCB1, NR3C1, IP013, GLCCI1).

Conclusions

DEX resulted in marked adrenal suppression suggesting that its potency relative to hydrocortisone and prednisone was underestimated. SNPs conferred significant differences in responses between subjects. Although preliminary, these pilot data suggest that incorporating pharmacogenetics has the potential to eventually lead to targeted therapy in children with CAH.

SUBMITTER: Nebesio TD 

PROVIDER: S-EPMC5036261 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia.

Nebesio Todd D TD   Renbarger Jamie L JL   Nabhan Zeina M ZM   Ross Sydney E SE   Slaven James E JE   Li Lang L   Walvoord Emily C EC   Eugster Erica A EA  

International journal of pediatric endocrinology 20160926


<h4>Background</h4>Little is known about the comparative effects of different glucocorticoids on the adrenal and growth hormone (GH) axes in children with congenital adrenal hyperplasia (CAH). We sought to compare the effects of hydrocortisone (HC), prednisone (PDN), and dexamethasone (DEX) in children with classic CAH and to investigate a potential role of pharmacogenetics.<h4>Methods</h4>Subjects were randomly assigned to three sequential 6-week courses of HC, PDN, and DEX, each followed by ev  ...[more]

Similar Datasets

| S-EPMC2943098 | biostudies-literature
| S-EPMC8063257 | biostudies-literature
| S-EPMC5155681 | biostudies-literature
| S-EPMC6166869 | biostudies-literature
| S-EPMC5576025 | biostudies-literature
| S-EPMC10083667 | biostudies-literature
| S-EPMC3583052 | biostudies-literature
| S-EPMC11606648 | biostudies-literature
| S-EPMC9156475 | biostudies-literature
| S-EPMC9302862 | biostudies-literature